The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Nov 2016

Latest Newsletter with interview with EDCTP High-Representatives dr Leonardo Simão and Prof. Marcel Tanner

Read more

Strategy 2014-2024

We published the updated concise Strategic Business Plan 2014-2024 with priorities per disease area.  See also the Strategic Research Agenda for 2017.







Read more

Call for Experts

Call for Experts: Implementation research and biomedical ethics – Scientific Advisory Committee. The Scientific Advisory Committee advises EDCTP on strategy. It is not involved in the review EDCTP calls for proposals.


Read more

Latest news

17 January 2017

Switzerland fully associated to Horizon 2020 per 1 January 2017

Switzerland became an Associated Country for the full Horizon 2020 programme as of 1 January 2017. Consequently, Switzerland has regained the possibility…

Read more
1 December 2016

World AIDS day 2016: EDCTP’s strategy for funding research on HIV

According to the AIDS by numbers 2016 report from UNAIDS, huge progress has been made in the fight against HIV…

Read more